Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2 is a research paper published in Cell Host & Microbe (2022). On theSindex it has a DataRank of 0. It has been cited 281 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI150473
NCI NIH HHS
Grant: U54 CA260582
NICHD NIH HHS
Grant: R01 HD095881
National Institutes of Health
Grant: 5R01HD095881-03
The impact of vitamin A on the gut-mammary gland-secretory IgA axis during enteric viral infections
National Institutes of Health
Grant: 3U54CA260582-02S3
Center for serological testing to improve outcomes from pandemic COVID-19 (STOP-COVID)
NCI
NIH
FWCI
26.42
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Additional file 1 of Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Additional file 2 of Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Additional file 2 of Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Additional file 1 of Cell-based passive immunization for protection against SARS-CoV-2 infection
Additional file 1 of Cell-based passive immunization for protection against SARS-CoV-2 infection